UBS raises Amgen target price to $530 from $470
AMGN•UBS raised its target price for Amgen to $530 from $470.
Related News
CoreWeave extends fall as Deutsche Bank and Citi trim price targets
CRWV•
NNN REIT Q3 revenue beats estimates, raises 2026 disposition guidance
NNN•
Rand Capital Q3 investment income falls 17% year over year
RAND•
UBS raises Xometry target price to $108 from $95
XMTR•
Luxfer shareholders approve acquisition by Wynnchurch Capital
LXFR•